tirzepatide drug mounjaro (Tirzepatide) Side Effects: What To Know What other health conditions are

People with a BMI of 27 or higher and one or more associated conditions to their weight such as high blood pressure are also great candidates

That tells you something about the intent behind the messaging

Semaglutide, the active ingredient in Wegovy and Ozempic, has strong clinical evidence for weight loss, though clinical trials showed tirzepatide achieved 20.2% average weight loss compared to semaglutide's 13.7%

At 25 degrees Celsius (77 degrees Fahrenheit), the peptide begins losing measurable potency within days

These are long-acting medications designed for once-weekly administration

Clinical trial data shows nausea affects approximately 44% of users, diarrhea hits about 30%, and vomiting is common especially during dose escalation